Tải xuống
Tóm tắt
ABSTRACT
Background: Hair is a human characteristic, which has an important role in presenting the individual gender, race, nation, social interaction as well as mental and physical health status. Chemotherapy-induced alopecia (CIA), which has an incidence of 65%, is known to be one of the most psychological shocks among cancer patients. Chemotherapy-induced Alopecia Distress Scale (CADS) created by a group of Korean scientists is a new tool developed to evaluate alopecia’s effects on patients’ mentality. It is necessary to
investigate the effects of alopecia on cancer patients and to understand the demands of patients in coping with CIA. However, to our knowledge, this is a topic that is still lacking objective and scientific evidence in Hue, Vietnam. Therefore, we conducted the study to describe the alopecia characteristics of patients treated with chemotherapy, and to identify the distress level of cancer patients using CADS and the preference of patients to deal with the alopecia.
Methods: A cross-sectional study was conducted on 56 cancer patients undergoing chemotherapy at the Oncology department of Hue University of Medicine and Pharmacy Hospital from 01/12/2020 to 25/03/2021. The hair loss grade was assessed by CTCAE and the level of distress was evaluated by CADS. Statistical analysis was performed in Microsoft Excel 2016 and the R 3.6.0 program.
Results: The mean age of patients in our study was 56.48 ± 10.244. Of all 56 patients, the majority of participants were female (69.6%), married (82.1%), and had above-average economic status (67.9%). Breast cancer patients accounted for the highest percentage with 39.3%. Most of the patients were in grade III (32.1%) and grade IV (39.3%). Our study revealed that 82.1% of patients having hair loss at grade 2 according to CTCAE 5.0. Evaluating by CADS showed that 87.5% of participants experienced low distress. Hat/ headscarf and wig were the most popular coping strategy against the CIA (66.1% and 35.7%, respectively). Scalp cooling is a new method that can prevent the CIA effectively. A proportion of 41.1% was willing to try the scalp cooling systems.
Conclusions: Alopecia grade 2 accounted for the majority of patients in our study (82.1%). This was a symptom that should be concerned, however, our study revealed that the alopecia’s effects were not so serious among patients in the study. Most of the patients did not worry about chemotherapy - induced alopecia (89.3%), and 87.5% of participants experienced low distress, while there was still a proportion of 12.5% with higher distress. To cope against alopecia, many feasible coping strategies have been used by patients, including hat/ headscarf or wig.
Tài liệu tham khảo
Yacoob Y, Davis LS. Detection and Analysis of Hair. 2006;28(7):1164-9.
Trusson D, Pilnick A. The role of hair loss in cancer identity. Cancer Nurs. 2017;40(2):E9-16.
Rossi A, Fortuna MC, Caro G, Pranteda G, Garelli V, Pompili U, et al. Chemotherapy - induced alopecia management: Clinical experience
and practical advice. J Cosmet Dermatol. 2017;16(4):537-41.
Howard (Jack) West M. Chemotherapy - Induced Hair Loss (Alopecia). JAMA Oncol. 2017;3(8):2019.
Titeca G, Goudetsidis L, Francq B, Sampogna F, Gieler U, Tomas - Aragones L, et al. The psychosocial burden of alopecia areata and androgenetica: a cross - sectional multicentre study among dermatological out - patients in 13 European countries. J Eur Acad Dermatology Venereol. 2020;34(2):406-11.
Clements ML. Chemotherapy - Induced Alopecia and Quality-of- Life : Ovarian and Uterine Cancer Patients and the Aesthetics of Disease. 2017;(June).
Saraswat N, Chopra A, Sood A, Kamboj P. A Descriptive Study to Analyze Chemotherapy -Induced Hair Loss and its Psychosocial Impact in Adults: Our Experience from a Tertiary Care Hospital. 2019;
Dunnill CJ, Collett A, Tameemi WA, Haslam IS. A Clinical and Biological Guide for Understanding Chemotherapy - Induced Alopecia and Its
Prevention. 2018;44(0):84-96.
Cho J, Choi EK, Kim IR, Im YH, Park YH, Lee S, et al. Development and validation of chemotherapy - induced alopecia distress scale
(CADS) for breast cancer patients. Ann Oncol. 2014;25(2):346-51.
Choi EK, Kim IR, Chang O, Kang D, Nam SJ, Lee JE, et al. Impact of chemotherapy-induced alopecia distress on body image, psychosocial well - being, and depression in breast cancer patients. Psychooncology. 2014;23(10):1103-10.
Wils R, Jacob A, Daniel E, Chacko R, Reka S. Distress and coping in cancer patients experiencing chemotherapy - induced alopecia. Indian J Contin Nurs Educ. 2019;20(1):60.
Kinoshita T, Nakayama T, Fukuma E, Inokuchi M. Efficacy of Scalp Cooling in Preventing and Recovering From Chemotherapy - Induced
Alopecia in Breast Cancer Patients: The HOPE Study. 2019;9(August):1-9.
Martín M, Montero JCDT, Tarruella SL, Casado KPA, Jerez Y. Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling. Breast Cancer Res Treat [Internet]. 2018;171(3):627-34.
U.S Department of Health and Human Services. Common Terminology Criteria for Adverse Events (CTCAE). 2017.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;0(0):1-41.
Borg L, Kennedy AG. Coping and the Psychosocial Impact of Alopecia Areata in Young Australians: An Exploratory Study. Thesis of Bachelor of Psychological Studies, School of Social Sciences and Psychology, Victoria University, Australia. 2012. Available at: https://aaaf.org.au/wpcontent/uploads/2017/04/Psychosocial-ImpactAA-youths-Thesis-2012.pdf.
Lemieux J, Amireault C, Provencher L, Maunsell E. Incidence of scalp metastases in breast cancer: A retrospective cohort study in women who were offered scalp cooling. Breast Cancer Res Treat. 2009;118(3):547-52.
Kate S, Patil R, Pathan D, Vyavhare R, Joseph S, Baby V, et al. Safety and efficacy of scalp cooling system in preventing chemotherapy induced alopecia - A single-center prospective study. Cancer Treat Res Commun. 2021;26:100280.
Hoffer L, Achdut N, Shvarts S, Segal - Engelchin D. Gender differences in psychosocial outcomes of hair loss resulting from childhood irradiation for tinea capitis. Int J Environ Res Public Health. 2021;18,7825.
Koyama, A., Matsuoka, H., Ohtake, Y. et al. Gender differences in cancer-related distress in Japan: a retrospective observation study.
BioPsychoSocial Med. 2016;10, 10.
Zakowski SG, Harris C, Krueger N et al. Social barriers to emotional expression and their relations to distress in male and female cancer patients. Br J Health Psychol. 2003; 8(3):271-86.
| Đã xuất bản | 24-01-2025 | |
| Toàn văn |
|
|
| Ngôn ngữ |
|
|
| Số tạp chí | Số 72 (2021) | |
| Phân mục | Nghiên cứu | |
| DOI | 10.38103/jcmhch.2021.72.11 | |
| Từ khóa | Keywords: Alopecia, Chemotherapy, Distress, Cancer, CADS, Scalp cooling |
công trình này được cấp phép theo Creative Commons Attribution-phi thương mại-NoDerivatives 4.0 License International .
Bản quyền (c) 2021 Tạp chí Y học lâm sàng Bệnh viện Trung Ương Huế